|
MRPL18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.910000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.730400E-01 |
| Normal-vs-Stage2 |
2.577800E-01 |
| Normal-vs-Stage3 |
3.576600E-01 |
| Normal-vs-Stage4 |
5.264600E-01 |
| Stage1-vs-Stage2 |
7.410300E-02 |
| Stage1-vs-Stage3 |
5.860400E-02 |
| Stage1-vs-Stage4 |
9.261200E-01 |
| Stage2-vs-Stage3 |
7.525400E-01 |
| Stage2-vs-Stage4 |
1.065760E-01 |
| Stage3-vs-Stage4 |
1.626390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.626800E-01 |
| Normal-vs-AfricanAmerican |
6.533000E-01 |
| Normal-vs-Asian |
3.597800E-02 |
| Caucasian-vs-AfricanAmerican |
8.335400E-01 |
| Caucasian-vs-Asian |
1.008070E-02 |
| AfricanAmerican-vs-Asian |
3.103600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.095400E-01 |
| Normal-vs-Female |
9.367000E-01 |
| Male-vs-Female |
8.203000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.260400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.668600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.989200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.118400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.494000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.662100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.590000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.526800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.815200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.341800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.467000E-01 |
| Classical-VS-Follicular |
1.715780E-01 |
| Classical-VS-Other |
4.855800E-01 |
| Classical-VS-Normal |
5.866800E-01 |
| Tall-VS-Follicular |
6.435800E-01 |
| Tall-VS-Other |
2.910200E-01 |
| Tall-VS-Normal |
9.774200E-01 |
| Follicular-VS-Other |
2.224600E-01 |
| Follicular-VS-Normal |
4.915800E-01 |
| Other-VS-Normal |
4.132800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.655200E-01 |
| Normal-vs-N1 |
1.566440E-01 |
| N0-vs-N1 |
5.881600E-02 |
|
|
